CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer.

Yunha NamChang-Min ChoiYoung Soo ParkHyunA JungHee Sang HwangJae Cheol LeeJung Wook LeeJung Eun LeeJung Hee KangByung Hun JungWonjun Ji

Published in: Journal of clinical medicine (2022)

Old age, male sex, and high pathological stage were poor prognostic factors in patients with NSCLC who underwent surgical resection. Furthermore, CDCP1 expression could serve as a biomarker for poor prognosis in stage I NSCLC.

Keyphrases

poor prognosis
prognostic factors
long non coding rna
small cell lung cancer
advanced non small cell lung cancer
lymph node
binding protein
epidermal growth factor receptor